Gene: ELAPOR1
Official Full Name: endosome-lysosome associated apoptosis and autophagy regulator 1provided by HGNC
Gene Summary: Expression of this gene is induced by estrogen and the encoded protein has been characterized as a transmembrane protein. The encoded protein has been found in to correlate with survival in certain carcinomas (PMID: 21102415) and may be important for cellular response to stress (PMID: 21072319). Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18037 | ELAPOR1 Knockout cell line (HeLa) | Human | ELAPOR1 | 1:3~1:6 | Negative | Online Inquiry |
ELAPOR1 Gene Knockout Cell Lines are meticulously developed cellular models designed to facilitate the study of the ELAPOR1 gene's role in various biological processes. The ELAPOR1 gene is implicated in the regulation of cellular signaling pathways involved in immune response and cancer progression. By utilizing CRISPR-Cas9 gene-editing technology, our knockout cell lines provide a powerful tool for researchers seeking to elucidate the functional dynamics of this gene and its influence on cellular behavior.
These ELAPOR1 knockout cell lines operate through a precise mechanism that disrupts the expression of the ELAPOR1 gene, allowing for the analysis of resultant phenotypic changes. When researchers observe these changes, they can glean insights into the gene's functions, particularly in intricate processes like cellular proliferation, differentiation, and apoptosis. By studying these cell lines, scientists can enhance their understanding of disease mechanisms, drug interactions, and potential therapeutic targets particularly relevant to immunology and oncology research.
The scientific importance of these knockout cell lines is profound, as they serve as invaluable tools in both laboratory and clinical settings. Their applications span drug discovery, functional genomics, and the development of gene therapies aimed at mitigating conditions linked to ELAPOR1 misregulation. Compared to traditional knockout models, our ELAPOR1 cell lines offer superior specificity and efficiency, reducing experimental variability and enabling precise validation of experimental hypotheses.
Moreover, our ELAPOR1 Gene Knockout Cell Lines are cultivated under rigorously controlled conditions, ensuring high viability and reproducibility for experimental demands. For researchers and clinicians aiming to push the boundaries of genetic research and therapeutic advancements, these cell lines present a compelling, reliable resource.
At [Company Name], we pride ourselves on our expertise in biological product development, delivering high-quality research tools that empower scientists to unravel the complexities of gene function and disease biology. Partner with us to enhance your research capabilities and drive innovation in your field.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.